T 2086/21 of 14.05.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T208621.20240514
- Date of decision
- 14 May 2024
- Case number
- T 2086/21
- Petition for review of
- -
- Application number
- 13800681.2
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- Abstract on EPC2000 Art 056
- Application title
- CRYSTALLINE FORMS OF AN ANDROGEN RECEPTOR MODULATOR
- Applicant name
- Aragon Pharmaceuticals, Inc.
Sloan-Kettering Institute for Cancer Research - Opponent name
- Sagittarius Intellectual Property LLP
Generics (U.K.) Limited
Luigi, Rumi - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 13(2)
- Keywords
- Inventive step
- Catchword
- Inventive step of crystalline form: unexpected beneficial combination of properties - yes (points 3.5.5 and 3.6 of the reasons)
- Citing cases
- -
Order
For these reasons it is decided that:
The appeals are dismissed.